Heron Therapeutics, Inc. (HRTX) KPIs and segments
Close on Nov 17, 2026Market cap $53.58MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Heron Therapeutics's business
Heron Therapeutics's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CINVANTI($M) | 21.8 | 20.5 | 22.9 | 24.0 | 24.1 | 25.7 | 26.9 | 22.7 | 24.9 | 25.6 | 24.3 | 23.3 | |
ZYNRELEF($M) | 11.1 | 10.2 | 12.5 | 9.31 | 8.19 | 8.04 | 8.46 | 6.25 | 5.83 | 5.01 | 5.69 | 4.37 | |
APONVIE($M) | 4.28 | 3.39 | 3.81 | 3.03 | 2.46 | 2.26 | 1.93 | 1.14 | 1.02 | 0.43 | 0.47 | 0.35 | |
SUSTOL($M) | 0.54 | 0.55 | 1.33 | 1.91 | 2.40 | 2.86 | 3.52 | 2.76 | 4.25 | 3.62 | 3.80 | 3.44 | |
Rentable area1 | |||||||||||||
Canada(M sq ft) | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | ||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-10.
See a number that looks wrong?